CSI Market
Sign In | Register

Theratechnologies Inc (THTX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access THTX Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Theratechnologies Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Nov 30 2024)
12 Months 		0 0 0 (Nov 30 2023)
Operating Activities
Income-6.30
Depreciation & amortization0.98
Amortization of Other Assets1.44
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.11
Adjustments For Depreciation Expense-
Adjustments For Amortisation Expense-
Adjustments For Increase Decrease In Employee Benefit Liabilities-
Interest On Convertible Unsecured Senior Notes And Long Term Loan-
Adjustments For Interest Income-
Adjustments For Income Tax Expense-
Income Taxes Paid Classified As Operating Activities-
Adjustments For Decrease Increase In Other Current Assets-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Provisions-
Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities-
Adjustments For Amortization Of Rightofuse Assets-
Adjustments For Sharebased Payments-
Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill-
Gain Loss On Lease Termination-
Income taxes0.00
Losses/ -gains on Investments net0.02
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities14.69
Discontinued operations0.00
Net Cash flow from Operating Activities2.38
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities2.82
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Acquire Derivative Financial Assets-
Other Inflows Outflows Of Cash Classified As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.49
Payments for (Proceeds from) Deposits0.00
Purchase Of Financial Instruments Classified As Investing Activities0.44
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-1.50
Discontinued operations0.00
Net Cash Flow from Investing Activities0.94
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings60.60
Long-term debt - repayments45.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.49
Proceeds From Exercise Of Broker Options-
Payments For Debt Issue Costs-
Repayment Of Other Obligations-
Proceeds From Exercise Of Warrants-
Proceeds From Issuing Shares And Warrants-
Payments For Share Issue Costs-
Adjustments For Deferred Financing Costs-
Repayments For Debt Issue Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-21.49
Effect of exchange rate on cash flow-0.03
Discontinued operations0.00
Free Cash Flow2.38
Total Cash Flow34.10
4 historic quarters locked

Sign in to unlock the full Theratechnologies Inc cash flow history.

Sign In Create Free Account

About Theratechnologies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

  • Form: 20-F (Period: 20241130)
  • Filed with the SEC: February 26, 2025
  • Source: d857007d20f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-035910

Figures are derived from filed reports and may be restated. Historical data is subject to revision.